Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.
While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.
For momentum investors, upward or downward trends in a stock’s price or earnings outlook take precedent, so they’ll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
San Francisco, CA-based Hims & Hers Health, Inc. is a consumer-centric health and wellness platform that redefines healthcare through personalized solutions and seamless digital access. Launched in 2017, the company specializes in subscription-based services and retail partnerships, catering to a broad range of health needs across key therapeutic categories. The company operates under dual revenue streams — online subscriptions and wholesale retail.
HIMS is a Zacks Rank #1 (Strong Buy) stock, with a Momentum Style Score of B and VGM Score of B. Shares are down 8.5% over the past one week and up 13.4% over the past four weeks. HIMS has gained 134% in the last one-year period as well. Looking at trading volume, an average of 33,722,048 shares exchanged hands over the last 20 trading days.
Momentum investors don’t just pay attention to price changes; positive earnings play a crucial role, too. One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.02 to $0.75 per share. HIMS boasts an average earnings surprise of 19.6%.
With strong earnings growth, a good Zacks Rank, and top-tier Momentum and VGM Style Scores, investors should think about adding HIMS to their portfolios.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
